Wataru Hirose

Tohoku University

Papers

1

Total Citations

5

H-Index

1

About

Dr. Wataru Hirose is a leading surgical oncologist specializing in the multidisciplinary management of esophageal cancer, with a particular focus on salvage treatments for recurrent disease after chemoradiotherapy (CRT). His major contributions center on optimizing the therapeutic sequence for patients with locally recurrent esophageal cancer, specifically investigating the role and limitations of photodynamic therapy (PDT) as a less invasive salvage option. In his highly cited 2021 work, Dr. Hirose critically examined the depth of PDT’s effects and its potential for tissue damage, providing essential data that helps clinicians decide when PDT is appropriate versus when salvage esophagectomy remains necessary. This research has been cited 5 times, reflecting its growing influence in guiding treatment algorithms for this challenging patient population. Dr. Hirose’s work bridges the gap between endoscopic and surgical approaches, offering a nuanced understanding of how to balance organ preservation with oncologic efficacy. His contributions are particularly valuable for surgeons and gastroenterologists navigating the complex decision-making in recurrent esophageal cancer, where treatment options are limited and patient outcomes depend on precise, evidence-based sequencing of therapies.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Salvage esophagectomy for local recurrent esophageal cancer after definitive chemoradiotherapy followed by photodynamic therapy
5 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Tohoku University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago